Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Polymyalgia rheumatica and temporal arteritis].

P A J M Vos1, J W J Bijlsma, R H W M Derksen

  • 1Universitair Medisch Centrum Utrecht, afd. Rheumatologie en Klinische Immunologie, Heidelberglaan 100, 3584 CX Utrecht.

Nederlands Tijdschrift Voor Geneeskunde
|September 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births".

Journal of immunology research·2022
Same author

Sex-specific differences and how to handle them in early psoriatic arthritis.

Arthritis research & therapy·2022
Same author

Towards developing diagnostic criteria for early knee osteoarthritis: data from the CHECK study.

Rheumatology (Oxford, England)·2020
Same author

The multi-biomarker disease activity test for assessing response to treatment strategies using methotrexate with or without prednisone in the CAMERA-II trial.

Arthritis research & therapy·2020
Same author

Effectiveness of Remission Induction Strategies for Early Rheumatoid Arthritis: a Systematic Literature Review.

Current rheumatology reports·2019
Same author

Cross-sectional survey of the undergraduate rheumatology curriculum in European medical schools: a EULAR School of Rheumatology initiative.

RMD open·2018

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are inflammatory conditions affecting individuals over 50. Standard treatment involves glucocorticoids, with osteoporosis prophylaxis recommended due to long-term use.

Area of Science:

  • Rheumatology
  • Immunology
  • Vascular Medicine

Background:

  • Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are common inflammatory diseases in those over 50.
  • PMR presents with aching and stiffness in girdles and neck; GCA involves large artery vasculitis with symptoms like headache and visual disturbances.

Discussion:

  • GCA is characterized by panarteritis with macrophage activation.
  • Glucocorticoids are the standard treatment for both PMR and GCA.
  • High-dose intravenous glucocorticoids are used for GCA with recent vision impairment.

Key Insights:

  • PMR and GCA are closely related inflammatory conditions.
  • Treatment duration for PMR and GCA is typically 1-2 years.
  • Osteoporosis prophylaxis (calcium, vitamin D, bisphosphonates) is crucial for patients on long-term glucocorticoids.

Related Experiment Videos

Outlook:

  • Further research into the pathogenesis of PMR and GCA may reveal novel therapeutic targets.
  • Exploring alternative or steroid-sparing treatments could mitigate long-term side effects.
  • Longitudinal studies are needed to optimize management strategies and patient outcomes.